Dexamethasone/Ixazomib/Rituximab Regimen

Preferred Label : Dexamethasone/Ixazomib/Rituximab Regimen;

NCIt synonyms : Dexamethasone/Ixazomib Plus Rituximab Regimen; Ixazomib/Dexamethasone Plus Rituximab; Ixazomib/Dexamethasone Plus Rituximab Regimen; IDR Regimen; IRD; IRD Regimen; Decadron/Ninlaro/Rituxan; Dexamethasone/Ixazomib/Rituximab; Dexamethasone-Ixazomib-Rituximab; Dexamethasone-Ixazomib-Rituximab Regimen; IDR;

NCIt related terms : IDR (rituximab-arrx); IDR (rituximab-rixa); IDR (rituximab-pvvr); IDR (rituximab-blit); IDR (rituximab-abbs); IDR (rituximab-rixi); IDR (rituximab-rite);

NCIt definition : A regimen consisting of dexamethasone, ixazomib and rituximab that may be used for the treatment of Waldenstrom macroglobulinemia and lymphoplasmacytic lymphoma.;

NCI Metathesaurus CUI : CL1799360;

Codes from synonyms : 34262; 128639; 128796; 128011; 128325; 127854; 128482; 128168;

Détails

Origin ID

C190720;

UMLS CUI

C5781752;

Automatic exact mappings (from CISMeF team)
- Infantile Refsum disease [ORDO Disease]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Dexamethasone [NCIt concept]
- Ixazomib Citrate [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients